DOWN-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN A HUMAN COLON-CARCINOMA CELL-LINE TRANSFECTED WITH AN ANTISENSE EXPRESSION VECTOR SPECIFIC FOR C-SRC
Lm. Ellis et al., DOWN-REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN A HUMAN COLON-CARCINOMA CELL-LINE TRANSFECTED WITH AN ANTISENSE EXPRESSION VECTOR SPECIFIC FOR C-SRC, The Journal of biological chemistry, 273(2), 1998, pp. 1052-1057
Vascular endothelial growth factor (VEGF) is implicated in the angioge
nesis of human colon cancer. Recent evidence suggests that factors tha
t regulate VEGF expression may partially depend on c-src-mediated sign
al transduction pathways. The tyrosine kinase activity of Src is activ
ated in most colon tumors and cell lines, We established stable subclo
nes of the human colon adenocarcinoma cell line HT29 in which Src expr
ession and activity are decreased specifically as a result of a transf
ected antisense expression vector. This study determined whether VEGF
expression is decreased in these cell lines and whether the smaller si
ze and reduced growth rate of antisense vector-transfected cell lines
in vivo might result, in part, from reduced vascularization of tumors.
Northern blot analysis of these cell lines revealed that VEGF mRNA ex
pression was decreased in proportion to the decrease in Src kinase act
ivity. Under hypoxic conditions, cells with decreased Src activity had
a <2-fold increase in VEGF expression, whereas parental cells had a >
50-fold increase. VEGF protein in the supernatants of cells was also r
educed in antisense transfectants compared with that from parental cel
ls, In nude mice, subcutaneous tumors from antisense transfectants sho
wed a significant reduction in vascularity. These results suggest that
Src activity regulates the expression of VEGF in colon tumor cells.